CLINICAL_TRIALS
trial_result
· 2013-12-12
Clinical Trial Update: Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria [Phase 3]
Summary
A Phase 3 trial comparing the efficacy and safety of levocetirizine versus loratadine for chronic idiopathic urticaria has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Pharma | Conditions: Urticaria | Phase 3 | Status: COMPLETED